Weekly Digest: New diabetes clinical trial (14 items)

New diabetes clinical trial: SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan Published on: September 27, 2021 at 07:00PM Conditions:   Type2 Diabetes;   Heart Failure With Preserved Ejection Fraction Interventions:   Drug: Empagliflozin 25 MG;   Drug: Placebo Sponsors:   The University of Texas Health Science Center at San Antonio;   Doris Duke Charitable Foundation Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05057806?term=diabetes&sfpd_d=14 September 27, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass Published on: September 27, 2021 at 07:00PM Conditions:   Dumping Syndrome;   Hypoglycemia, Reactive Interventions:   Drug: Empagliflozin 25 MG;   Drug: Placebo Sponsor:   University Hospital Inselspital, Berne Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05057819?term=diabetes&sfpd_d=14 September 27, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: A Clinical Research on Disease Progression and Intervention of Chronic HepatitisB Published on: September 27, 2021 at 07:00PM Condition:   Hepatitis B, Chronic Intervention:   Sponsor:   Hong Ren Recruiting https://clinicaltrials.gov/ct2/show/NCT05057065?term=diabetes&sfpd_d=14 September 27, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: UK Imaging Diabetes Study Seeing Diabetes Clearly Published on: September 27, 2021 at 07:00PM Conditions:   Type2 Diabetes;   Diabetic Retinopathy Intervention:   Sponsors:   Perspectum;   Moorfields Eye Hospital NHS Foundation Trust Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05057403?term=diabetes&sfpd_d=14 September 27, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics Published on: September 28, 2021 at 07:00PM Condition:   Cystinuria Intervention:   Drug: Dapagliflozin Sponsor:   University of California, San Francisco Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05058859?term=diabetes&sfpd_d=14 September 28, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Artificial Intelligence to Improve Cardiometabolic Risk Evaluation Using CT Scans Published on: September 28, 2021 at 07:00PM Conditions:   Pre-diabetes;   Diabetes Mellitus Intervention:   Diagnostic Test: Oral Glucose Tolerance Test Sponsors:   Caristo Diagnostics Limited;   University of Oxford;   University of Leeds;   Milton Keynes University Hospital NHS Foundation Trust Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05058690?term=diabetes&sfpd_d=14 September 28, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Dexcom Hybrid Closed Loop Insulin Pump Study in Type 1 Diabetes Published on: September 28, 2021 at 07:00PM Condition:   Type 1 Diabetes Mellitus Intervention:   Device: Tandem Control IQ Hybrid Closed Loop Insulin Delivery System Sponsors:   NHS Lothian;   DexCom, Inc.;   NHS Tayside Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05059860?term=diabetes&sfpd_d=14 September 28, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: The Expression of circANKRD36 as a New Biomarker of Diabetic Nephropathy Published on: September 29, 2021 at 07:00PM Condition:   Diabetic Nephropathy Intervention:   Genetic: circANKRD36 as a new biomarker Sponsor:   Assiut University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05061459?term=diabetes&sfpd_d=14 September 29, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: A Double-blinded, Randomized, Parallel, Placebo-controlled Trial of Wharton's Jelly-derived Allogeneic Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents Published on: September 29, 2021 at 07:00PM Condition:   Type1diabetes Intervention:   Biological: the ATMP Protrans Sponsor:   Uppsala University Hospital Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05061030?term=diabetes&sfpd_d=14 September 29, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Biomechanical and Viscoelastic Properties of Plantar Fascia in Diabetes Mellitus Published on: September 29, 2021 at 07:00PM Condition:   Diabetes Mellitus Intervention:   Diagnostic Test: Evaluation of biomechanics and viscoelastic properties of plantar fascia Sponsor:   Bitlis Eren University Recruiting https://clinicaltrials.gov/ct2/show/NCT05061602?term=diabetes&sfpd_d=14 September 29, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Glucose Testing in GDM: Adherence to One- Versus Two-hour Postprandial Glucose Monitoring in Gestational Diabetics Published on: September 30, 2021 at 07:00PM Condition:   Gestational Diabetes Interventions:   Other: 1 hour Blood glucose monitoring;   Other: 2 hour blood glucose monitoring Sponsor:   Weill Medical College of Cornell University Enrolling by invitation https://clinicaltrials.gov/ct2/show/NCT05062460?term=diabetes&sfpd_d=14 October 01, 2021 at 01:22AM via ClinicalTrials.gov New diabetes clinical trial: Help Everyone Assess Risk Today: LEnten Nutrition Study (HEART-LENS) Published on: September 27, 2021 at 07:00PM Conditions:   Cardiovascular Morbidity;   Risk Reduction;   Nutrition Disorders Intervention:   Dietary Supplement: Vegan diet Sponsor:   Rush University Medical Center Completed https://clinicaltrials.gov/ct2/show/NCT05057650?term=diabetes&sfpd_d=14 October 01, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. Published on: October 01, 2021 at 07:00PM Conditions:   Diabetes Mellitus;   Diabetic Retinopathy;   Diabetic Macular Edema Interventions:   Drug: THR-687 dose level 1;   Drug: THR-687 dose level 2;   Drug: THR-687 selected dose level;   Drug: Aflibercept Sponsor:   Oxurion Recruiting https://clinicaltrials.gov/ct2/show/NCT05063734?term=diabetes&sfpd_d=14 October 01, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes Published on: October 01, 2021 at 07:00PM Condition:   Type 2 Diabetes Mellitus Interventions:   Drug: TG103;   Drug: Placebo Sponsor:   CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05063253?term=diabetes&sfpd_d=14 October 01, 2021 at 02:22PM via ClinicalTrials.gov